Clinical trial Recruiting at 1 site Interventional Ages 50 and up

SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults

Official title: Sheba Healthspan Research Population (SHARP) Trial

Run by Sheba Medical Center · NCT07596576 · Data updated 2026-11-12

A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment1500 (estimated)
SponsorSheba Medical Center
Government
Drugs / interventionschemotherapy, radiation
Locations1 site (Ramat Gan, Tel Aviv)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedMarch 1, 2027
Study endsDecember 1, 2027
Registry record updatedMay 19, 2026
Trial IDNCT07596576 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy men and women over 50 who live in the community and can attend study visits.

Probably not a fit

Individuals with significant cognitive impairment, neurodegenerative disease, psychiatric illness, or recent cancer therapy may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study randomizes healthy community-dwelling adults over 50 to receive a personalized health and behavioral intervention based on an integrative systems approach, with biomarker and functional outcomes tracked at baseline, 6 months, and 12 months. Participants in the intervention group are guided by a tailored plan and monitored through a purpose-built app to track adherence and physiology. Comprehensive baseline and follow-up assessments include metabolic lab work, immune and hormonal panels, microbiome and proteomics analyses, physical and imaging measures, cognitive and mental health evaluations, and lifestyle data. Primary endpoints focus on changes in biological aging markers, while secondary endpoints assess functional and cognitive performance.

Why it matters

Potential benefit: If successful, the program could slow aspects of biological aging and support better physical and cognitive function in older adults.

How similar studies have gone: Prior research in aging and lifestyle interventions has shown potential to influence biomarkers of aging, but results vary and this study evaluates a comprehensive, personalized protocol.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy older adults \>50 years old men and women

Exclusion Criteria:

1. A former diagnostic of a significant cognitive reduction (MoCa score \< 24 ).
2. Former diagnosis of neurodegenerative disease as Alzheimer's disease, Parkinson's disease, Lewy body dementia.
3. Former diagnosis of psychiatric disease.
4. In the past two years, underwent chemotherapy or radiation therapy.

Where it's running

  • Sheba Medical Center
    Ramat Gan, Tel Aviv, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.